Autoimmune Hepatitis clinical trials at UC Davis

1 research study open to eligible people

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
open to eligible people ages 18-75
VAY736 dose testing; VAY736 efficacy and safety testing.
Sacramento, California and other locations

Last updated: September 16, 2024